Utama › Leukemia Mieloid Kronik › Texas › Houston
Kajian klinikal Leukemia Mieloid Kronik di Houston, TX
18 kajian untuk Leukemia Mieloid Kronik sedang mencari peserta di lokasi dalam dan sekitar Houston (dalam lingkungan kira-kira 30 batu). Buka kajian untuk melihat siapa yang layak menyertai dan cara menghubungi pasukan kajian.
Teks kajian rasmi (Bahasa Inggeris)
Mengambil peserta untuk kajian di sini? Paparkan di bahagian atas halaman ini — $99 selama 30 hari →
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
Mengambil pesertaKajian pemerhatianSukarelawan sihat dialu-alukan
- UT MD Anderson Cancer Center, Houston
Pharmacokinetic Study of Venetoclax Tablets Crushed and Dissolved Into a Solution
Mengambil pesertaKajian pemerhatian
- Texas Children's Hospital, Houston
Phase II Study Assessing the Efficacy and Toxicity of Olverembatinib Monotherapy in Patients With Chronic Myeloid Leukemia in Chronic Phase After Failing One Prior Therapy With a Second Generation Tyrosine Kinase Inhibitor or Asciminib
Mengambil pesertaFasa 2
- MD Anderson Cancer Center, Houston
Phase II Study Assessing the Safety and Efficacy of Dasatinib in Combination With Ropeginterferon in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase
Mengambil pesertaFasa 2
- The University of Texas M. D. Anderson Cancer Center, Houston
Phase II Study Assessing Efficacy and Safety of Asciminib in Patients With Newly Diagnosed Chronic Myeloid Leukemia in Chronic Phase.
Mengambil pesertaFasa 2
- MD Anderson Cancer Center, Houston
Edetate Calcium Disodium or Succimer in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome Undergoing Chemotherapy
Mengambil pesertaFasa 1
- M D Anderson Cancer Center, Houston
Ponatinib Hydrochloride as Second Line Therapy in Treating Patients With Chronic Myeloid Leukemia in Chronic Phase Resistant or Intolerant to Imatinib Mesylate, Dasatinib, or Nilotinib
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Study of Olverembatinib (HQP1351) in Patients With CML-CP
Mengambil pesertaFasa 3
- Ascentage Investigative Site #1501, Houston
A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs)
Mengambil pesertaKajian pemerhatian
- M.D. Anderson Cancer Center, Houston
- Texas Children's Hospital - Baylor Medical Center, Houston
Asciminib Roll-over Study
Mengambil pesertaFasa 4
- Uni Of TX MD Anderson Cancer Cntr, Houston
Cladribine, Idarubicin, Cytarabine, and Venetoclax in Treating Patients With Acute Myeloid Leukemia, High-Risk Myelodysplastic Syndrome, or Blastic Phase Chronic Myeloid Leukemia
Mengambil pesertaFasa 2
- M D Anderson Cancer Center, Houston
Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial
Mengambil pesertaKajian pemerhatian
- University of Texas MD Anderson Cancer Center, Houston
A Phase 1a/1b Study of ELVN-001 for the Treatment Chronic Myeloid Leukemia
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
Mengambil pesertaFasa 2
- MD Anderson, Houston
A Study of CBX-250 in Participants With Relapsed or Refractory Myeloid Leukemias
Mengambil pesertaFasa 1
- MD Anderson Cancer Center, Houston
A Phase 1/2 Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Efficacy of TERN-701 in Participants With Chronic Myeloid Leukemia (CARDINAL)
Mengambil pesertaFasa 1/2
- The University of Texas M.D. Anderson Cancer Center, Houston
Study of HQP1351 in Subjects With Refractory CML and Ph+ ALL
Mengambil pesertaFasa 1
- University of Texas MD Anderson Cancer Center, Houston
TGRX-678 US Phase I for Subjects with Refractory or Advanced Chronic Myelogenous Leukemia
Mengambil pesertaFasa 1
- The University of Texas MD Anderson Cancer Center, Houston
Kajian Leukemia Mieloid Kronik di bandar lain
- Seattle, WA11 kajian
- New York City, NY11 kajian
- Detroit, MI6 kajian
- Birmingham, AL6 kajian
- Philadelphia, PA6 kajian
- Chicago, IL6 kajian
- Baldwin Park, CA6 kajian
- Portland, OR6 kajian
- Nashville, TN5 kajian
- Columbus, OH5 kajian
- Milwaukee, WI5 kajian
- Baltimore, MD5 kajian
Kajian lain di Houston
- Kanser Paru-paru Bukan Sel Kecil145 kajian
- Kanser Payudara126 kajian
- Kanser (semua jenis)121 kajian
- Kanser Metastatik104 kajian
- Kanser Kolorektal102 kajian
- Kanser Ovari89 kajian
- Leukemia Mieloid Akut85 kajian
- Kanser Paru-paru78 kajian
- Kanser Prostat76 kajian
- Kanser Endometrium68 kajian
- Kanser Pankreas61 kajian
- Melanoma59 kajian
Daripada ClinicalTrials.gov, data diperoleh pada 5 Okt 2026. Setiap kajian menetapkan kriteria kelayakannya sendiri; pasukan kajian menentukan siapa yang layak menyertai.